Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
14.28
-0.45 (-3.05%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
489,198
Open
14.81
Bid (Size)
14.09 (1)
Ask (Size)
15.21 (1)
Prev. Close
14.73
Today's Range
14.13 - 15.07
52wk Range
12.95 - 25.47
Shares Outstanding
90,900,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2024
From
Arcus Biosciences
Via
Business Wire
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
July 08, 2024
From
Arcus Biosciences
Via
Business Wire
Performance
YTD
-27.44%
-27.44%
1 Month
-11.80%
-11.80%
3 Month
-2.72%
-2.72%
6 Month
-5.49%
-5.49%
1 Year
-28.74%
-28.74%
More News
Read More
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences
July 08, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
June 25, 2024
From
Arcus Biosciences
Via
Business Wire
Navigating 5 Analyst Ratings For Arcus Biosciences
March 25, 2024
Via
Benzinga
Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
February 22, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
June 11, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
June 10, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 06, 2024
From
Arcus Biosciences
Via
Business Wire
After Disappointing Bladder Cancer Data, Gilead Announces Encouraging Data From Gastric, Colorectal Cancer Studies
June 03, 2024
Via
Benzinga
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
June 02, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
June 01, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
May 24, 2024
From
Arcus Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 24, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
May 09, 2024
From
Arcus Biosciences
Via
Business Wire
RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
May 08, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
May 02, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
April 24, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
April 23, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
March 26, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
March 11, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
February 28, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 27, 2024
From
Arcus Biosciences
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.